Vimta Labs Ltd.
Snapshot View

View in App

Prices View details >>

311.55 +8.20 ▲2.7%

31 March 2023, 04:01:00 PM
Volume: 4,970

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.vimta.com
Market Cap 695.40 Cr.
Enterprise Value(EV) 686.46 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.39 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 14.57 Trailing Twelve Months Ending 2022-12
Industry PE 46.34 Trailing Twelve Months Ending 2022-12
Book Value / Share 120.90 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.58 Calculated using Price: 311.55
Dividend Yield 0.64 Period Ending 2022-03
No. of Shares Subscribed 2.21 Cr. 22,128,989 Shares
FaceValue 2
Company Profile
Vimta Labs is India's leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.70%
1 Week
-2.38%
1 Month
+3.01%
3 Month
-28.81%
6 Month
-8.23%
1 Year
-1.13%
2 Year
+93.57%
5 Year
+77.57%
10 Year
+1977.00%

Ratios View Details >>

3 years 2020-03 2021-03 2022-03
Return on Equity (%) 3.96 11.66 19.43
Return on Capital Employed (%) 5.84 14.25 23.92
Return on Assets (%) 2.79 8.25 14.29

Balance Sheet View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 173 194 234 257
Non Curr. Liab. 15 25 23 22
Curr. Liab. 58 54 48 59
Minority Int.
Equity & Liab. 245 273 305 337
Non Curr. Assets 149 163 181 186
Curr. Assets 96 111 124 151
Misc. Exp. not W/O
Total Assets 245 273 305 337

Profit Loss View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 181 211 278 310
Other Income 3 1 1 3
Total Income 184 212 280 314
Total Expenditure -151 -158 -198 -217
PBIDT 33 54 82 97
Interest -4 -2 -2 -3
Depreciation -21 -23 -23 -29
Taxation -1 -7 -14 -17
Exceptional Items -1
PAT 7 21 41 47
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 7 21 41 47
Adjusted EPS 3 10 19 21

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 24 37 59
Cash Fr. Inv. -21 -32 -38
Cash Fr. Finan. -1 -5 -17
Net Change 3 1 5
Cash & Cash Eqvt 6 6 11

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 37.46 37.46 37.46 37.46 37.46 37.46 37.46 37.46 37.25
Public 62.54 62.54 62.54 62.54 62.54 62.54 62.54 62.54 62.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 31 Mar 2023
Closure of Trading Window
Intimation for closure of Trading Window be closed from 1st April 2023 till 48 hours after the declaration of audited financial results of the Company for the fourth quarter and year ended 31st March 2023.
Fri, 31 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding receipt of Information for loss of share certificate.
Tue, 14 Feb 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 6160 Employee Stock Options under Vimta Labs Employee Stock Option Plan 2021.

Technical Scans View Details >>

Fri, 31 Mar 2023
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Vimta Labs Ltd.

What is Vimta Labs share price?
Can I buy Vimta Labs shares now?
What is the Dividend Yield of Vimta Labs?
What is the Market Cap of Vimta Labs?
What are the key metrics to analyse Vimta Labs?
What is the 52 Week High and Low of Vimta Labs?
What is the trend of Vimta Labs share price?